MRZM News and Press, Marizyme Inc

JUPITER, FL - ( NewMediaWire ) - May 06, 2024 - Marizyme, Inc. (OTCQB: MRZM) is pleased to announce that its flagship product DuraGraft ®   will no longer require refrigerated storage and will be able to be stored at controlled room temperatures of 20 o C-25 o C allowing it to be ...

JUPITER, FL - ( NewMediaWire ) - April 16, 2024 - Marizyme, Inc. ("Marizyme", OTCQB: MRZM) announces today a Co-Development Agreement (the “Agreement”)  with  Qualigen Therapeutics, Inc.  (“Qualigen”) (NASDAQ:  QLGN ) to advance the commercial...

--News Direct-- Marizyme Inc CEO David Barthel joined Steve Darling from Proactive to provide an exciting update on the remarkable progress that the company has achieved in recent months. Among the standout developments is the approval received from the US Food and Drug Administration for...

VANCOUVER, BC / ACCESSWIRE / October 13, 2023 / Marizyme, Inc. (OTCQB:MRZM), a global multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes, is featured in today's video by InvestmentPitch M...

VANCOUVER, BC / ACCESSWIRE / October 6, 2023 / The Watchlist by The Market Herald has announced the release of new interviews with FPX Nickel, Pelangio Exploration, Nicola Mining, and Max Resource discussing their latest news. The Watchlist by The Market Herald provides investors with a quick s...

DuraGraft is the first and only FDA cleared medical device for use as an intra-operative vascular conduit storage and flushing solution used during CABG surgeries   JUPITER, FL - ( NewMediaWire ) - October 06, 2023 - Marizyme, Inc. (OTCQB:MRZM) (“Marizyme” or the ...

DuraGraft is the first and only FDA cleared medical device for use as an intra-operative vascular conduit storage and flushing solution used during CABG surgeries JUPITER, FL, Oct. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Marizyme, Inc. (OTCQB:MRZM) (“Marizyme&#x...

JUPITER, FL - ( NewMediaWire ) - May 10, 2023 - Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), a multi-technology biomedical company focused on the accelerated development and commercialization of medical technologies that improve patient health outcomes, announced today that it ha...

JUPITER, FL, May 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), a multi-technology biomedical company focused on the accelerated development and commercialization of medical technologies that improve patient health outcomes, ...

JUPITER, FL - ( NewMediaWire ) - May 03, 2023 - Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), today provided the following business update to the stockholders and the investing public from the Company’s Chief Executive Officer, David Barthel. I am pleased to bring you an...